{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:19Z","timestamp":1741238659079,"version":"3.38.0"},"reference-count":26,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nephro.2022.04.003","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T23:06:14Z","timestamp":1663369574000},"page":"549-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus treatment after short-term intravenous methylprednisolone in incipient minimal change disease for adults: A retrospective analysis"],"prefix":"10.1684","volume":"18","author":[{"given":"Ya","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liugen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruman","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2022.04.003_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000167603","article-title":"Minimal-change glomerulopathy of adulthood","volume":"8","author":"Korbet","year":"1988","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivareli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.04.003_bib0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000046215","article-title":"Adult-onset minimal change among Taiwanese: clinical features, therapeutic response, and prognosis","volume":"21","author":"Huang","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ndt\/gfp422","article-title":"Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome","volume":"25","author":"Eguchi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.04.003_bib0160","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/ndt\/gfm637","article-title":"Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome","volume":"23","author":"Li","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.04.003_bib0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35001102","article-title":"How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis","volume":"403","author":"Glynne","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nephro.2022.04.003_bib0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.2009.198","article-title":"Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens","volume":"76","author":"Presser","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.04.003_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.transproceed.2005.12.083","article-title":"Renal function and tubular phosphate handling in long-term cyclosporineand tacrolimus-based immunosuppression in kidney transplantation","volume":"38","author":"Falkiewicz","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2022.04.003_bib0180","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1432-2277.2006.00359.x","article-title":"The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients","volume":"19","author":"Koefoed-Nielsen","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.nephro.2022.04.003_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106164","article-title":"The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4","volume":"9","author":"Peng","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.nephro.2022.04.003_bib0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/gfu306","article-title":"Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus","volume":"30","author":"Caro","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.04.003_bib0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.krcp.2012.04.321","article-title":"Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: a pilot study","volume":"31","author":"Kim","year":"2012","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.nephro.2022.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1681\/ASN.2016030342","article-title":"Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome","volume":"28","author":"Li","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0205","first-page":"479","article-title":"Diagnosis and management of nephrotic syndrome in adults","volume":"93","author":"Kodner","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.nephro.2022.04.003_bib0210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12882-015-0199-x","article-title":"Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study","volume":"16","author":"Liu","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0220","first-page":"177","article-title":"Chapter\u00a05: Minimal-change disease in adults","volume":"S2","author":"KDIGO guidelines.","year":"2012","journal-title":"Kid Int"},{"key":"10.1016\/j.nephro.2022.04.003_bib0225","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/ndt\/gft207","article-title":"Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure","volume":"28","author":"Li","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.04.003_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2215\/CJN.06180519","article-title":"Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease: a multicenter, randomized, controlled trial","volume":"15","author":"Medjeral-Thomas","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.04.003_bib0235","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/1319-2442.252902","article-title":"Tacrolimus as the first-line agent in adult-onset minimal change disease: a randomized controlled study","volume":"30","author":"Patil","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.nephro.2022.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/13543784.16.7.1099","article-title":"Tacrolimus in the treatment of idiopathic nephrotic syndrome","volume":"16","author":"Westhoff","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.nephro.2022.04.003_bib0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0961203306073167","article-title":"A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade","volume":"16","author":"Tse","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.nephro.2022.04.003_bib0250","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/0929867003374723","article-title":"FK506, an immunosuppressant targeting calcineurin function","volume":"7","author":"Dumont","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nephro.2022.04.003_bib0255","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.nephro.2022.04.003_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/S0041-1345(99)00788-5","article-title":"Pharmacokinetics of tacrolimus: clinically relevant aspects","volume":"31","author":"Undre","year":"1999","journal-title":"Transplant Proc"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2022.04.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:17:05Z","timestamp":1741191425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725522001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1769725522001274"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2022.04.003","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus treatment after short-term intravenous methylprednisolone in incipient minimal change disease for adults: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2022.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation.","name":"copyright","label":"Copyright"}]}}